180 related articles for article (PubMed ID: 31259527)
1. Spatiotemporal Tracking of Brain-Tumor-Associated Myeloid Cells
SoRelle ED; Yecies DW; Liba O; Bennett FC; Graef CM; Dutta R; Mitra S; Joubert LM; Cheshier S; Grant GA; de la Zerda A
ACS Nano; 2019 Jul; 13(7):7985-7995. PubMed ID: 31259527
[TBL] [Abstract][Full Text] [Related]
2. Speckle modulation enables high-resolution wide-field human brain tumor margin detection and in vivo murine neuroimaging.
Yecies D; Liba O; SoRelle ED; Dutta R; Yuan E; Vogel H; Grant GA; de la Zerda A
Sci Rep; 2019 Jul; 9(1):10388. PubMed ID: 31316099
[TBL] [Abstract][Full Text] [Related]
3. Biofunctionalization of Large Gold Nanorods Realizes Ultrahigh-Sensitivity Optical Imaging Agents.
SoRelle ED; Liba O; Hussain Z; Gambhir M; de la Zerda A
Langmuir; 2015 Nov; 31(45):12339-47. PubMed ID: 26477361
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced optical coherence tomography with picomolar sensitivity for functional in vivo imaging.
Liba O; SoRelle ED; Sen D; de la Zerda A
Sci Rep; 2016 Mar; 6():23337. PubMed ID: 26987475
[TBL] [Abstract][Full Text] [Related]
5. Real-Time Detection of Circulating Tumor Cells in Living Animals Using Functionalized Large Gold Nanorods.
Dutta R; Liba O; SoRelle ED; Winetraub Y; Ramani VC; Jeffrey SS; Sledge GW; de la Zerda A
Nano Lett; 2019 Apr; 19(4):2334-2342. PubMed ID: 30895796
[TBL] [Abstract][Full Text] [Related]
6. Gold Nanobipyramids as Second Near Infrared Optical Coherence Tomography Contrast Agents for
Si P; Shevidi S; Yuan E; Yuan K; Lautman Z; Jeffrey SS; Sledge GW; de la Zerda A
Nano Lett; 2020 Jan; 20(1):101-108. PubMed ID: 31585502
[TBL] [Abstract][Full Text] [Related]
7. Gold Nanoprisms as Optical Coherence Tomography Contrast Agents in the Second Near-Infrared Window for Enhanced Angiography in Live Animals.
Si P; Yuan E; Liba O; Winetraub Y; Yousefi S; SoRelle ED; Yecies DW; Dutta R; de la Zerda A
ACS Nano; 2018 Dec; 12(12):11986-11994. PubMed ID: 30422624
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence contrast imaging using gold nanorods in living mice eyes.
de la Zerda A; Prabhulkar S; Perez VL; Ruggeri M; Paranjape AS; Habte F; Gambhir SS; Awdeh RM
Clin Exp Ophthalmol; 2015; 43(4):358-66. PubMed ID: 24533647
[TBL] [Abstract][Full Text] [Related]
9. Retroreflective-type Janus microspheres as a novel contrast agent for enhanced optical coherence tomography.
Zhang J; Liu J; Wang LM; Li ZY; Yuan Z
J Biophotonics; 2017 Jun; 10(6-7):878-886. PubMed ID: 27218690
[TBL] [Abstract][Full Text] [Related]
10. Spectral fractionation detection of gold nanorod contrast agents using optical coherence tomography.
Jia Y; Liu G; Gordon AY; Gao SS; Pechauer AD; Stoddard J; McGill TJ; Jayagopal A; Huang D
Opt Express; 2015 Feb; 23(4):4212-25. PubMed ID: 25836459
[TBL] [Abstract][Full Text] [Related]
11. High-resolution contrast-enhanced optical coherence tomography in mice retinae.
Sen D; SoRelle ED; Liba O; Dalal R; Paulus YM; Kim TW; Moshfeghi DM; de la Zerda A
J Biomed Opt; 2016 Jun; 21(6):66002. PubMed ID: 27264492
[TBL] [Abstract][Full Text] [Related]
12. Depth-Resolved Enhanced Spectral-Domain OCT Imaging of Live Mammalian Embryos Using Gold Nanoparticles as Contrast Agent.
Huang Y; Li M; Huang D; Qiu Q; Lin W; Liu J; Yang W; Yao Y; Yan G; Qu N; Tuchin VV; Fan S; Liu G; Zhao Q; Chen X
Small; 2019 Aug; 15(35):e1902346. PubMed ID: 31304667
[TBL] [Abstract][Full Text] [Related]
13. Laser brain cancer surgery in a xenograft model guided by optical coherence tomography.
Katta N; Estrada AD; McElroy AB; Gruslova A; Oglesby M; Cabe AG; Feldman MD; Fleming RD; Brenner AJ; Milner TE
Theranostics; 2019; 9(12):3555-3564. PubMed ID: 31281497
[TBL] [Abstract][Full Text] [Related]
14. Time-domain and spectral-domain optical coherence tomography in the analysis of brain tumor tissue.
Böhringer HJ; Boller D; Leppert J; Knopp U; Lankenau E; Reusche E; Hüttmann G; Giese A
Lasers Surg Med; 2006 Jul; 38(6):588-97. PubMed ID: 16736504
[TBL] [Abstract][Full Text] [Related]
15. Optical clearing of melanoma in vivo: characterization by diffuse reflectance spectroscopy and optical coherence tomography.
Pires L; Demidov V; Vitkin IA; Bagnato V; Kurachi C; Wilson BC
J Biomed Opt; 2016 Aug; 21(8):081210. PubMed ID: 27300502
[TBL] [Abstract][Full Text] [Related]
16. Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo.
Kah JC; Olivo M; Chow TH; Song KS; Koh KZ; Mhaisalkar S; Sheppard CJ
J Biomed Opt; 2009; 14(5):054015. PubMed ID: 19895117
[TBL] [Abstract][Full Text] [Related]
17. Plasmonic chiral contrast agents for optical coherence tomography: numerical study.
Mehta KB; Chen N
Opt Express; 2011 Aug; 19(16):14903-12. PubMed ID: 21934851
[TBL] [Abstract][Full Text] [Related]
18. Speckle-modulating optical coherence tomography in living mice and humans.
Liba O; Lew MD; SoRelle ED; Dutta R; Sen D; Moshfeghi DM; Chu S; de la Zerda A
Nat Commun; 2017 Jun; 8():15845. PubMed ID: 28632205
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal, label-free, quantitative tracking of cell death and viability in a 3D tumor model with OCT.
Jung Y; Klein OJ; Wang H; Evans CL
Sci Rep; 2016 Jun; 6():27017. PubMed ID: 27248849
[TBL] [Abstract][Full Text] [Related]
20. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
